Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lindholm, Lars H, Ibsen, Hans, Dahlöf, Björn, Devereux, Richard B, Beevers, Gareth, de Faire, Ulf, Fyhrquist, Frej, Julius, Stevo, Kjeldsen, Sverre E, Kristiansson, Krister, Lederballe-Pedersen, Ole, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans, Aurup, Peter, Edelman, Jonathan and Snapinn, Steven and LIFE study group (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet, 359 (9311). pp. 1004-1010. ISSN 1474-547X

Full text not available from this repository.
Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:
Related URLs:
Depositing User: Rhiannon Harvey
Date Deposited: 01 Jul 2011 11:13
Last Modified: 03 Nov 2022 15:32
URI: https://ueaeprints.uea.ac.uk/id/eprint/33181
DOI: 10.1016/S0140-6736(02)08090-X

Actions (login required)

View Item View Item